title: Higher acute insulin response to glucose may determine greater free fatty acid clearance in African-American women.
abstract: BACKGROUND
  Obesity and diabetes are more common in African-Americans than whites. Because free fatty acids (FFA) participate in the development of these conditions, studying race differences in the regulation of FFA and glucose by insulin is essential.
  
  
  OBJECTIVE
  The objective of the study was to determine whether race differences exist in glucose and FFA response to insulin.
  
  
  METHODS
  This was a cross-sectional study.
  
  
  METHODS
  The study was conducted at a clinical research center.
  
  
  METHODS
  Thirty-four premenopausal women (17 African-Americans, 17 whites) matched for age [36 ± 10 yr (mean ± sd)] and body mass index (30.0 ± 6.7 kg/m²).
  
  
  METHODS
  Insulin-modified frequently sampled iv glucose tolerance tests were performed with data analyzed by separate minimal models for glucose and FFA.
  
  
  METHODS
  Glucose measures were insulin sensitivity index (S(I)) and acute insulin response to glucose (AIRg). FFA measures were FFA clearance rate (c(f)).
  
  
  RESULTS
  Body mass index was similar but fat mass was higher in African-Americans than whites (P < 0.01). Compared with whites, African-Americans had lower S(I) (3.71 ± 1.55 vs. 5.23 ± 2.74 [×10⁻⁴ min⁻¹/(microunits per milliliter)] (P = 0.05) and higher AIRg (642 ± 379 vs. 263 ± 206 mU/liter⁻¹ · min, P < 0.01). Adjusting for fat mass, African-Americans had higher FFA clearance, c(f) (0.13 ± 0.06 vs. 0.08 ± 0.05 min⁻¹, P < 0.01). After adjusting for AIRg, the race difference in c(f) was no longer present (P = 0.51). For all women, the relationship between c(f) and AIRg was significant (r = 0.64, P < 0.01), but the relationship between c(f) and S(I) was not (r = -0.07, P = 0.71). The same pattern persisted when the two groups were studied separately.
  
  
  CONCLUSIONS
  African-American women were more insulin resistant than white women, yet they had greater FFA clearance. Acutely higher insulin concentrations in African-American women accounted for higher FFA clearance.
authors: Laboratory of Biological Modeling, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
authors: Carson C
authors: CC
authors: Chow
authors: Vipul
authors: V
authors: Periwal
authors: Gyorgy
authors: G
authors: Csako
authors: Madia
authors: M
authors: Ricks
authors: Amber B
authors: AB
authors: Courville
authors: Bernard V
authors: BV
authors: Miller
authors: Gloria L
authors: GL
authors: Vega
authors: Anne E
authors: AE
authors: Sumner
references: JAMA. 2010 Jan 20;303(3):235-41
references: 20071471
references: Essays Biochem. 2006;42:89-103
references: 17144882
references: Metabolism. 2004 Sep;53(9):1202-7
references: 15334385
references: Diabetes. 2000 Mar;49(3):399-408
references: 10868961
references: Cell Metab. 2008 Feb;7(2):95-6
references: 18249166
references: Metabolism. 1990 Jun;39(6):595-7
references: 2191188
references: Diabetologia. 1997 Jul;40(7):850-8
references: 9243108
references: Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1932-8
references: 10938014
references: Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E131-6
references: 20424137
references: Diabetes. 1996 Jun;45(6):742-8
references: 8635647
references: Obesity (Silver Spring). 2011 Mar;19(3):671-4
references: 20847732
references: Metabolism. 2005 Jul;54(7):902-9
references: 15988699
references: J Clin Invest. 1995 Nov;96(5):2297-303
references: 7593616
references: Diabetes Technol Ther. 2003;5(6):1003-15
references: 14709204
references: N Engl J Med. 1989 Apr 20;320(16):1060-8
references: 2648155
references: Am J Clin Nutr. 2002 Nov;76(5):975-9
references: 12399268
references: Diabet Med. 1994 Oct;11(8):755-62
references: 7851069
references: Diabetes. 2003 Oct;52(10):2461-74
references: 14514628
references: Am J Physiol. 1979 Jun;236(6):E667-77
references: 443421
references: J Clin Invest. 1991 Aug;88(2):609-13
references: 1864970
references: J Clin Invest. 2000 Aug;106(3):421-30
references: 10930445
references: Diabetes Care. 2006 Jun;29(6):1263-8
references: 16732006
references: Curr Diab Rep. 2005 Jun;5(3):167-70
references: 15929861
references: Diabetes Metab Res Rev. 2002 Mar-Apr;18(2):149-55
references: 11994907
references: J Clin Endocrinol Metab. 1992 Apr;74(4):806-10
references: 1548345
references: Am J Physiol Regul Integr Comp Physiol. 2008 Oct;295(4):R1089-96
references: 18685069
references: Endocrinol Metab Clin North Am. 2008 Sep;37(3):635-46, viii-ix
references: 18775356
references: Diabetologia. 1975 Feb;11(1):83-8
references: 1170119
references: Atherosclerosis. 2008 Feb;196(2):696-703
references: 17254586
references: J Clin Invest. 2003 Jan;111(2):257-64
references: 12531882
references: J Clin Endocrinol Metab. 2011 Feb;96(2):541-7
references: 21123445
references: Hepatology. 2009 Mar;49(3):791-801
references: 19105205
references: Am J Physiol Endocrinol Metab. 2000 May;278(5):E941-8
references: 10780952
references: Diabetes. 2002 Feb;51 Suppl 1:S212-20
references: 11815482
references: Curr Opin Lipidol. 2007 Jun;18(3):246-50
references: 17495596
references: Trends Endocrinol Metab. 2000 Nov;11(9):351-6
references: 11042464
references: J Clin Endocrinol Metab. 2007 Dec;92(12):4656-63
references: 17878257